From: Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer
Prognostic factors | Overall Cohort | EGFRm Cohort | PD-L1 positive Cohort | |||
---|---|---|---|---|---|---|
HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | |
Smoking | ||||||
 Never | Ref |  | Ref |  | Ref |  |
 Current or former | 1.55 (1.03–2.34) | 0.033 | 2.12 (1.15–3.89) | 0.015 | 0.44 (0.15–1.22) | 0.117 |
COPD | ||||||
 No | Ref |  | Ref |  | Ref |  |
 Yes | 1.72 (0.98–3.01) | 0.054 | 1.39 (0.43–0.46) | 0.572 | 0.51 (0.11–2.23) | 0.375 |
CEA | ||||||
  < 3.8 ng/ml | Ref |  | Ref |  | Ref |  |
  ≥ 3.8 ng/ml | 2.57 (1.57–4.19) |  < 0.001 | 4.84 (2.23–10.46) |  < 0.001 | 1.75 (0.55–5.56) | 0.339 |
pT | ||||||
 pT1 | Ref |  | Ref |  | Ref |  |
 pT2a | 2.02 (1.27–3.20) | 0.003 | 1.91 (1.05–3.46) | 0.031 | 2.44 (0.82–7.29) | 0.108 |
 pT2b | 3.73 (2.03–6.85) |  < 0.001 | 3.80 (1.62–8.97) | 0.002 | 0.94 (0.11–7.92) | 0.961 |
 pT3 | 3.81 (2.30–6.30) |  < 0.001 | 2.22 (0.95–5.19) | 0.064 | 3.90 (1.09–13.94) | 0.036 |
 pT4 | 4.98 (2.42–10.24) |  < 0.001 | 4.73 (1.41–15.83) | 0.012 | 2.16 (0.25–18.29) | 0.477 |
pN | ||||||
 pN0 | Ref |  | Ref |  | Ref |  |
 pN1 | 3.88 (2.33–6.44) |  < 0.001 | 2.93 (1.48–5.78) | 0.002 | 2.01 (0.40–10.07) | 0.395 |
 pN2 | 4.31 (2.18–8.53) |  < 0.001 | 5.69 (3.08–10.51) |  < 0.001 | 7.43 (2.72–20.31) |  < 0.001 |
pStage | ||||||
 I | Ref |  | Ref |  | Ref |  |
 II | 3.30 (2.12–5.13) |  < 0.001 | 2.15 (1.11–4.17) | 0.022 | 7.16 (1.37–37.24) | 0.019 |
 III | 6.74 (4.40–10.33) |  < 0.001 | 6.53 (3.65–11.69) |  < 0.001 | 14.27 (3.18–64.02) | 0.001 |
Margin | ||||||
 Negative | Ref |  | Ref |  | Ref |  |
 Positive | 4.31 (2.18–8.53) |  < 0.001 | 3.81 (1.52–9.59) | 0.004 | 1.44 (0.18–11.02) | 0.724 |
LVI | ||||||
 Negative | Ref |  | Ref |  | Ref |  |
 Positive | 3.28 (2.27–4.74) |  < 0.001 | 3.22 (1.90–5.43) |  < 0.001 | 5.96 (1.73–20.51) | 0.005 |
Pleural invasion | ||||||
 Negative | Ref |  | Ref |  | Ref |  |
 Positive | 2.35 (1.61–3.42) |  < 0.001 | 2.18 (1.28–3.71) | 0.004 | 1.58 (0.59–4.18) | 0.354 |
Histology | ||||||
 Lepidic | Ref |  | Ref |  | Ref |  |
 Acinar | 2.59 (1.46–4.60) | 0.001 | 3.54 (1.49–8.42) | 0.004 | 0.91 (0.19–4.32) | 0.908 |
 Micropapillary | 5.41 (2.29–12.78) |  < 0.001 | 4.33 (0.87–21.54) | 0.073 | 1.25 (0.23–6.72) | 0.789 |
 Papillary | 4.15 (2.02–8.50) |  < 0.001 | 4.58 (1.62–12.94) | 0.004 |  | 1 |
 Solid | 4.86 (2.27–10.40) |  < 0.001 | 10.66 (2.97–38.22) |  < 0.001 | 0.45 (0.072–2.85) | 0.401 |
 Mucinous | 2.83 (1.27–6.30) |  < 0.001 | 6.69 (1.33–33.49) | 0.021 | 0.73 (0.06–8.10) | 0.801 |
EGFR status | ||||||
 Wild-type | Ref |  | - |  | - |  |
 Mutated | 0.88 (0.60–1.28) | 0.518 | - |  | - |  |
PDL1 SP263 | ||||||
 Negative | Ref |  | - |  | - |  |
  ≥ 1 | 1.75 (1.03–2.98) | 0.036 | - |  | - |  |